Abstract:RNA viruses cause numerous infectious diseases in humans and animals. The crosstalk between RNA viruses and the innate DNA sensing pathways attracts increasing attention. Recent studies showed that the cGAS-STING pathway plays an important role in restricting RNA viruses via mitochondria DNA (mtDNA) mediated activation. However, the mechanisms of cGAS mediated innate immune evasion by RNA viruses remain unknown. Here, we report that seneca valley virus (SVV) protease 3C disrupts mtDNA mediated innate immune sensing by cleaving porcine cGAS (pcGAS) in a species-specific manner. Mechanistically, a W/Q motif within the N-terminal domain of pcGAS is a unique cleavage site recognized by SVV 3C. Three conserved catalytic residues of SVV 3C cooperatively contribute to the cleavage of pcGAS, but not human cGAS (hcGAS) or mouse cGAS (mcGAS). Additionally, upon SVV infection and poly(dA:dT) transfection, pcGAS and SVV 3C colocalizes in the cells. Furthermore, SVV 3C disrupts pcGAS-mediated DNA binding, cGAMP synthesis and interferon induction by specifically cleaving pcGAS. This work uncovers a novel mechanism by which the viral protease cleaves the DNA sensor cGAS to evade innate immune response, suggesting a new antiviral approaches against picornaviruses. While the effect of cGAS on counteracting DNA viruses has been extensively studied, how cGAS restricts RNA viruses and how RNA viruses combat cGAS-mediated immune surveillance are largely unknown. Here, we show that picornavirus, seneca valley virus (SVV), infection causes the leakage of mitochondrial DNA into cytosol for cGAS activation, while SVV 3C protease cleaves porcine cGAS (pcGAS) in a species-specific manner to disrupt pcGAS-mediated DNA sensing, cGAMP synthesis and interferon induction. Importantly, we identify a W/Q motif within the N-terminal domain of pcGAS, which is unique among other species for SVV 3C cleavage. Three conserved catalytic residues of SVV 3C cooperatively contribute to the cleavage of pcGAS. These findings unravel a novel strategy for viral evasion of cGAS-mediated innate restriction.

Leaked Mitochondrial C1QBP Inhibits Activation of the DNA Sensor Cgas

PCBP1 Modulates the Innate Immune Response by Facilitating the Binding of Cgas to DNA

Cgas Modulates Cytokine Secretion and Bacterial Burdens by Altering the Release of Mitochondrial DNA in Pseudomonas Pulmonary Infection.

Crosstalk Between the Cgas DNA Sensor and Beclin-1 Autophagy Protein Shapes Innate Antimicrobial Immune Responses

Inhibition of RIG-I and MDA5-dependent Antiviral Response by Gc1qr at Mitochondria.

The Molecular Basis of Tight Nuclear Tethering and Inactivation of Cgas

Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release

cGAS is activated by DNA-induced oligomerization and has pivotal roles in antiviral defense and immune adjuvant effects

ZBP1 sequesters cGAS in the cytoplasm and sustains type I interferon responses to mitochondrial DNA

Dephosphorylation of cGAS by PPP6C impairs its substrate binding activity and innate antiviral response

Pivotal Roles of Cgas-Cgamp Signaling in Antiviral Defense and Immune Adjuvant Effects

Human Cytomegalovirus Protein UL42 Antagonizes Cgas/mita-Mediated Innate Antiviral Response

ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response

Species-specific cleavage of cGAS by picornavirus protease 3C disrupts mitochondria DNA-mediated immune sensing

Nuclear cGAS Functions Non-canonically to Enhance Antiviral Immunity via Recruiting Methyltransferase Prmt5

Endocytosis Triggers V-ATPase-SYK-mediated Priming of Cgas Activation and Innate Immune Response.

ZDHHC18 Negatively Regulates Cgas-Mediated Innate Immunity Through Palmitoylation.

Nonspecific DNA Binding of Cgas N Terminus Promotes Cgas Activation

Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates Cgas/sting-Mediated Antiviral Innate Immunity

Mitotic Inactivation of the Cgas‒mita/sting Pathways

Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway